Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. Research Outputs

Browsing by Author Huang J.-W.


Jump to:
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 22  next >
Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
2008A general model for sequential pattern mining with a progressive databaseHuang J.-W.; Tseng C.-Y.; Ou J.-C.; Chen M.-S.; MING-SYAN CHEN IEEE Transactions on Knowledge and Data Engineering 5733
2012Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activityChen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN ; Kim I.; Shiau C.-W.European Journal of Medicinal Chemistry6361
2021Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxelHuang J.-W.; CHING-HUA KUO ; Kuo H.-C.; JIN-YUAN SHIH ; Tsai T.-W.; LIN-CHAU CHANG PLoS ONE43
2018Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN ; Kim I.; Shiau C.-W.European Journal of Medicinal Chemistry11
2017Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047))Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F.Journal of Hepatology11
2017Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F.Journal of Hepatology01
2006Development of small-molecule cyclin D1-ablative agentsHuang J.-W.; Shiau C.-W.; Yang J.; Wang D.-S.; HAO-CHIEH CHIU ; Chen C.-Y.; Chen C.-S.Journal of Medicinal Chemistry5147
2021Differences in Fatty Acid Oxidation between Nab-Paclitaxel- And Solvent-Based Paclitaxel-Treated A549 Cells Based on MetabolomicsHuang J.-W.; CHING-HUA KUO ; Kuo H.-C.; JIN-YUAN SHIH ; Tsai T.-W.; LIN-CHAU CHANG ACS Omega22
2014Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinomaTai W.-T.; Shiau C.-W.; PEI-JER CHEN ; Chu P.-Y.; HSIANG-PO HUANG ; Liu C.-Y.; Huang J.-W.; Chen K.-F.Hepatology5455
2020Effects of nanomaterials on seedling growth and disease controlChang P.-F.L; Chang T.-H; Liu Y.-W; Chen C.-C; Li W.-Y; Chung W.-H; Lin J.-J; Huang J.-W.; JIANG-JEN LIN Acta Horticulturae00
2014Green Purchasing by MNC Subsidiaries: The Role of Local Tailoring in the Presence of Institutional DualityHsu P.-F; Hu P.J.-H; Wei C.-P; Huang J.-W.; CHIH-PING WEI Decision Sciences2419
2007How organizational climate and structure affect knowledge management-The social interaction perspectiveChen C.-J.; Huang J.-W.; CHUNG-JEN CHEN International Journal of Information Management374311
2013Interaction between lung cancer cell and myofibroblast influenced by cyclic tensile strainHuang J.-W.; Pan H.-J.; Yao W.-Y.; Tsao Y.-W.; WEI-YU LIAO ; Wu C.-W.; Tung Y.-C.; Lee C.-H.Lab on a Chip1716
2010Knowledge management and innovativeness: The role of organizational climate and structureChen C.-J.; Huang J.-W.; Hsiao Y.-C.; CHUNG-JEN CHEN International Journal of Manpower197146
2019The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA LabelWang Y.-H.; Chen C.-B.; Tassaneeyakul W.; Saito Y.; Aihara M.; Choon S.E.; Lee H.Y.; Chang M.M.; Roa F.D.; Wu C.-W.; Zhang J.; Nakkam N.; Konyoung P.; Okamoto-Uchida Y.; Cheung C.M.-T.; Huang J.-W.; Ji C.; Cheng B.; Hui R.C.-Y.; CHIA-YU CHU ; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Huang Y.-H.; Lu C.-W.; Yang C.-Y.; Lin Y.-T.; Chi M.-H.; Ho H.-C.; Lin J.-Y.; Yang C.-H.; Chang Y.-C.; Su S.-C.; Wang C.W.; Fan W.-L.; Hung S.-I.; Chung W.-H.; for the Asian Severe Cutaneous Adverse Reaction ConsortiumClinical Pharmacology and Therapeutics4240
2011Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass graftingTAO-MIN HUANG ; VIN-CENT WU ; Young G.-H.; YU-FENG LIN ; Shiao C.-C.; Wu P.-C.; WEN-YI LI ; HSI-YU YU ; Lin J.-W.; Chen Y.-S.; YIH-SHARNG CHEN ; YEN-HUNG LIN ; SHOEI-SHEN WANG ; RON-BIN HSU ; FAN-CHI CHANG ; NAI-KUAN CHOU ; TZONG-SHINN CHU ; Tsai P.-R.; Huang J.-W.; JENQ-WEN HUANG ; SHUEI-LIONG LIN ; YUNG-MING CHEN ; Ko W.-J.; Wu K.-D.Journal of the American Society of Nephrology132122
2014SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma modelTai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN ; Chen K.-F.Molecular Cancer Therapeutics66
2011Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinomaTai W.-T.; ANN-LII CHENG ; Shiau C.-W.; HSIANG-PO HUANG ; Huang J.-W.; PEI-JER CHEN ; Chen K.-F.Journal of Hepatology141137
2011Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of RafChen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; ANN-LII CHENG ; PEI-JER CHEN ; Shiau C.-W.European Journal of Medicinal Chemistry3126
2009Strategic human resource practices and innovation performance - The mediating role of knowledge management capacityChen C.-J.; Huang J.-W.; CHUNG-JEN CHEN Journal of Business Research886752
Showing results 1 to 20 of 22  next >

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback